Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate COVID-19-infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05656443
What this trial is testing

Study of GST-HG171/Ritonavir Compared With Placebo in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19 Pneumonia
Fujian Akeylink Biotechnology Co., Ltd. 1,246
Testing effectiveness (Phase 2)UnknownNCT04977960
What this trial is testing

Efficacy of Canrenone as add-on Treatment in Moderate to Severe ARDS in COVID-19

Who this might be right for
COVID-19 Acute Respiratory Distress Syndrome
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 180
Not applicableEnded earlyNCT04654325
What this trial is testing

Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients

Who this might be right for
SARS-CoV-2
Assistance Publique - Hôpitaux de Paris 534
Testing effectiveness (Phase 2)Ended earlyNCT05124210
What this trial is testing

Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19

Who this might be right for
COVID-19
GlaxoSmithKline 8
Testing effectiveness (Phase 2)UnknownNCT04920760
What this trial is testing

Vitamin A Supplementation in Children With Moderate to Severe COVID-19

Who this might be right for
Covid19
Shiraz University of Medical Sciences 60
Testing effectiveness (Phase 2)Ended earlyNCT04847583
What this trial is testing

Evaluate Biomarker Change, Efficacy, Pharmacokinetics, Safety and Tolerability of Telacebec (Q203) in Covid-19 Patients

Who this might be right for
COVID-19 Virus Infection
Qurient Co., Ltd. 1
Not applicableStudy completedNCT04325906
What this trial is testing

Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS

Who this might be right for
Prone PositioningHigh Flow Nasal CannulaAcute Respiratory Distress Syndrome+1 more
Rush University Medical Center 224
Testing effectiveness (Phase 2)Study completedNCT05676073
What this trial is testing

Study of SHEN26 Capsule in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Shenzhen Kexing Pharmaceutical Co., Ltd. 91
Not applicableStudy completedNCT04412551
What this trial is testing

Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19

Who this might be right for
Corona Virus InfectionVirus DiseasesCoronaviridae Infections
Dalarna County Council, Sweden 72
Not applicableStudy completedNCT05911022
What this trial is testing

Probiotic and Colchicine in COVID-19

Who this might be right for
COVID-19
Ain Shams University 150
Large-scale testing (Phase 3)Study completedNCT05321394
What this trial is testing

Non-inferiority Trial on Treatments in Early COVID-19

Who this might be right for
COVID-19
Azienda Ospedaliera Universitaria Integrata Verona 536
Testing effectiveness (Phase 2)Study completedNCT04399356
What this trial is testing

Niclosamide for Mild to Moderate COVID-19

Who this might be right for
COVID-19
Tufts Medical Center 73
Large-scale testing (Phase 3)Study completedNCT05716425
What this trial is testing

Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)

Who this might be right for
COVID-19
Zhejiang ACEA Pharmaceutical Co. Ltd. 1,218
Testing effectiveness (Phase 2)WithdrawnNCT04436458
What this trial is testing

Niclosamide In Moderate COVID-19

Who this might be right for
COVID
Entero Therapeutics
Testing effectiveness (Phase 2)Study completedNCT05076253
What this trial is testing

Efficacy of Ivermectin in COVID-19

Who this might be right for
SafetySARS-CoV2 InfectionIvermectin Poisoning+1 more
Bangkok Metropolitan Administration Medical College and Vajira Hospital 72
Testing effectiveness (Phase 2)Temporarily pausedNCT04711863
What this trial is testing

Fluvoxamine for Adults With Mild to Moderate COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2Coronavirus InfectionMild to Moderate COVID-19
Asan Medical Center 400
Large-scale testing (Phase 3)Ended earlyNCT04529499
What this trial is testing

Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients

Who this might be right for
Covid19
Dr. Reddy's Laboratories Limited 353
Large-scale testing (Phase 3)WithdrawnNCT04575064
What this trial is testing

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Who this might be right for
SARS-CoV-2 InfectionCOVID-19Moderate and Severe COVID-19
Professor Dr. Bernd Mühlbauer
Testing effectiveness (Phase 2)Ended earlyNCT04396106
What this trial is testing

Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting

Who this might be right for
COVID-19
Atea Pharmaceuticals, Inc. 83
Not applicableStudy completedNCT04348409
What this trial is testing

Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19

Who this might be right for
COVID-19
Azidus Brasil 50
Next Page